A Kinetic Model for Assessing Potential Nitrosamine Carcinogenicity.

Shu Yu1, J Christopher McWilliams1, Olivier Dirat2

  • 1Chemical Research and Development, Pfizer Research & Development, Groton, Connecticut 06340, United States.

PubMed
Summary

Assessing nitrosamine carcinogenicity is vital for safety limits. Two new computational models use quantum mechanics and data to predict the cancer-causing potential of nitrosamines, aiding in setting safe intake levels.